Safety of intravenous immunoglobulin (IVIG) therapy
- 31 March 2007
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 6 (4), 257-259
- https://doi.org/10.1016/j.autrev.2006.08.011
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Review: intravenous immunoglobulin therapy and thromboembolic complicationsLupus, 2005
- IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patientsAutoimmunity, 2005
- Intravenous Immunoglobulin: Adverse Effects and Safe AdministrationClinical Reviews in Allergy & Immunology, 2005
- Intravenous immunoglobulin and the kidney—a two-edged swordSeminars in Arthritis and Rheumatism, 2004
- IVIG for Autoimmune, Fibrosis, and Malignant Conditions: Our Experience with 200 PatientsJournal of Clinical Immunology, 2004
- Efficacy and Safety of Intravenous Immunoglobulin for Immune-Mediated Skin DiseaseAmerican Journal of Clinical Dermatology, 2004
- Risks associated with the use of intravenous immunoglobulinTransfusion Medicine Reviews, 2003
- Therapy with Intravenous Immunoglobulins: Complications and Side-EffectsEuropean Neurology, 2003
- Intravenous immune globulins: an update for cliniciansTransfusion, 2003
- Deep Venous Thrombosis of the Arm After Intravenous Immunoglobulin Infusion: Case Report and Literature Review of Intravenous Immunoglobulin-Related Thrombotic ComplicationsMayo Clinic Proceedings, 2000